订阅生命科学领域的最新动态
专家观点直达您的收件箱——选择您的兴趣。
绝无垃圾邮件。随时取消订阅。
Serialization in the EU can become a competitive advantage if you dare to innovate
In an attempt to reduce counterfeiting in the pharmaceutical industry, the European Union has issued the Falsified Medicine Directive (2011/62/EU).
2019年1月16日0 分钟阅读
Keep reading
Related articles
2026年2月13日
Deciding Early on an Orphan Strategy: A Strategic Choice, Not a Checkbox
Orphan strategy decisions go beyond incentives. Learn how regulatory definitions, evidence requirements, timing, and exclusivity across the EU, US, and UK shape early biotech development strategy.
阅读更多
2026年2月9日
Nitrosamine Impurities in Medicinal Products: Risks and Regulatory Insights
Learn about nitrosamine impurities in medicinal products, their causes, regulatory guidance, and strategies for risk evaluation and mitigation.
阅读更多
2025年10月27日
Environmental Risk Assessments (ERA) in Pharma: Balancing Health & Environment
Explore how Environmental Risk Assessment (ERA) helps ensure medicines heal us without harming the planet, balancing healthcare advances with ecological preservation.
阅读更多